Internal Medicine · Mount Vernon, NY
NPI
1578891503
Since 2009
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
12 N 7th Ave
Mount Vernon, NY, 10550
Phone (914) 664-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$284K
2,745 services
Medicare patients, 2024
1,052
Average age 73
Drug cost, 2024
$8.4M
2,990 prescriptions
Company payments, 2025
$923
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jiahuai Tan was code 99215 (office e&m - established), 1,446 times for 722 patients. In total Jiahuai Tan billed 2,745 services in 24 codes, and Medicare paid $284K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-12-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 1,446 | 722 | $114.78 | $166K |
| 99233 Hospital E&M - Subsequent | Facility | 581 | 161 | $93.01 | $54K |
| 99214 Office E&M - Established | Office | 385 | 354 | $75.92 | $29K |
| 99223 Hospital E&M - Initial | Facility | 74 | 71 | $134.60 | $9,960 |
| 99205 Office E&M - New | Office | 68 | 68 | $149.54 | $10K |
| 99222 Hospital E&M - Initial | Facility | 56 | 49 | $103.42 | $5,792 |
| 99213 Office E&M - Established | Office | 35 | 34 | $52.20 | $1,827 |
| 99204 Office E&M - New | Office | 22 | 22 | $105.58 | $2,323 |
| 99215 Office E&M - Established | Facility | 21 | 21 | $104.65 | $2,198 |
By year: 2022 $260K for 2,529 services; 2023 $351K for 3,154 services; 2024 $284K for 2,745 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 23 | 14 | $2.57 | $59.22 |
| 85025 Blood Count | 23 | 14 | $3.58 | $82.38 |
| 80053 Clinical Chemistry | 22 | 14 | $4.85 | $107 |
Medicare prescription drug claims, 2024
In 2024, the drug Jiahuai Tan prescribed most often to Medicare patients was Letrozole, with 449 prescriptions and refills. In total Jiahuai Tan wrote 2,990 Medicare prescriptions that cost $8.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 449 | 1,061 | 123 | $8,147 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 206 | 206 | 70 | $4,030 |
| Ondansetron Hcl Generic | 170 | 170 | 98 | $1,760 |
| Anastrozole Generic | 150 | 315 | 41 | $1,409 |
| Gabapentin Generic | 113 | 168 | 31 | $1,019 |
| Ibrance Palbociclib | 95 | 95 | 12 | $1.5M |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 83 | 83 | 34 | $2,067 |
| Tamoxifen Citrate Generic | 75 | 177 | 17 | $1,780 |
| Prednisone Generic | 72 | 80 | 31 | $429 |
| Eliquis Apixaban | 64 | 64 | Under 11 | $37K |
| Alprazolam Generic | 62 | 62 | 21 | $204 |
| Calquence Acalabrutinib Maleate | 48 | 48 | Under 11 | $602K |
| Revlimid Lenalidomide | 48 | 48 | 11 | $886K |
| Lenalidomide Generic | 47 | 47 | 12 | $611K |
| Venlafaxine Hcl Er Venlafaxine Hcl | 40 | 72 | Under 11 | $391 |
Brand drugs: 650 claims; generic drugs: 2,340 claims; opioid claims: 395.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jiahuai Tan $923 ($923 in general payments such as food, travel and fees) from 18 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $165.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $165 |
| Celgene Corporation BMY | 5 | $132 |
| Gilead Sciences, Inc. GILD | 4 | $112 |
| GlaxoSmithKline, LLC. GSK | 5 | $87.24 |
| Pfizer Inc. PFE | 4 | $79.54 |
| Genentech USA, Inc. ROG.SW | 1 | $53.45 |
| Abbvie Inc. ABBV | 3 | $48.89 |
| Genzyme Corporation SNY | 2 | $37.42 |
| Tempus AI, Inc TEM | 1 | $29.48 |
| Janssen Biotech, Inc. JNJ | 2 | $28.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.